Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Medulloblastoma 1Glioma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Brain Stem Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 5Temozolomide 4Radiation 3Irinotecan 3Bevacizumab 3ribociclib 2abemaciclib 2Vorinostat 2Mebendazole 2Everolimus 2Dasatinib 2vandetanib 1temsirolimus 1sargramostim 1reolysin 1pembrolizumab 1ovex 1nimotuzumab 1irinotecan sucrosofate 1dinutuximab 1crenolanib 1adavosertib 1Vincristine 1Valproic Acid 1Sirolimus 1Re-Irradiation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Piperazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diffuse Intrinsic Pontine Glioma × ovex × Clear all
NCT02644291 2022-06-23

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
16 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡